source
- FDA faces Roche blackmail claim, launches mifepristone safety study and reviews voucher program pause requestRoche has publicly accused the United States of blackmail in a dispute that surfaced in recent FDA discussions. The company’s allegation adds tension to ongoing regulatory dialogues. The Food and…
- Infinimmune appoints Srikanth Pendyala as new chief medical officerInfinimmune announced the addition of Srikanth Pendyala to its leadership team as chief medical officer. Pendyala comes to the role after serving in the same capacity at Stealth NewCo and Endeavor…